13F Data
13F filer · CIK 2077247

Trails Edge Capital Partners, LP

ATLANTA, GA · filing since Q4 2025 · last filing Aug 14, 2026
Reported value
$629.9M
+$193.4M vs prior
Positions
35
New / sold out
13 / 5
Added / reduced
10 / 7
Turnover
30.4%
buys $278.1M · sells $162.3M
Top-10 weight
50.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewFIRST TRACKS BIOTHERAPEUTICS+1,514,000–+$30.5M
NewBIOMARIN PHARMACEUTICAL INC+512,000–+$29.3M
NewINSMED INC+230,331–+$24.6M
NewKAILERA THERAPEUTICS INC+984,786–+$21.7M
NewINCYTE CORP+155,000–+$17.6M
AddedDESIGN THERAPEUTICS INC+1,149,269+134.9%+$16.6M
NewAVALO THERAPEUTICS INC+891,881–+$16.5M
NewMOONLAKE IMMUNOTHERAPEUTICS+750,000–+$14.6M
Added4D MOLECULAR THERAPEUTICS IN+925,000+71.0%+$12.3M
AddedIMMUNOCORE HLDGS PLC+380,637+55.8%+$12.1M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outVAXCYTE INC-662,470-100.0%$-38.5M
Sold outDEFINIUM THERAPEUTICS INC-1,738,110-100.0%$-32.9M
ReducedREVOLUTION MEDICINES INC-129,250-52.8%$-24.2M
Sold outARCUS BIOSCIENCES INC-1,047,935-100.0%$-22.6M
ReducedMIRUM PHARMACEUTICALS INC-110,000-33.0%$-12.9M
Sold outXENON PHARMACEUTICALS INCPUT-200,000-100.0%$-11.6M
Sold outIMMUNOVANT INC-414,054-100.0%$-10.3M
ReducedNURIX THERAPEUTICS INC-170,000-9.8%$-4.1M
ReducedNEUROGENE INC-67,902-8.7%$-2.1M
ReducedVTV THERAPEUTICS INC-54,386-39.0%$-2.0M
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $404.7MQ1 2026: $436.5MQ2 2026: $629.9M
Q4 2025Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1LB PHARMACEUTICALS INCCOM SHS1,523,022$49.4M7.85%
2NURIX THERAPEUTICS INCCOM1,573,220$38.2M6.06%
3IMMUNOCORE HLDGS PLCADS1,063,234$33.8M5.36%
4FIRST TRACKS BIOTHERAPEUTICSORD SHS1,514,000$30.5M4.84%
54D MOLECULAR THERAPEUTICS INCOM2,227,917$29.6M4.70%
6BIOMARIN PHARMACEUTICAL INCCOM512,000$29.3M4.65%
7DESIGN THERAPEUTICS INCCOM2,001,282$29.0M4.60%
8XENON PHARMACEUTICALS INCCOM440,000$26.6M4.22%
9MIRUM PHARMACEUTICALS INCCOM223,312$26.1M4.15%
10INSMED INCCOM PAR $.01230,331$24.6M3.90%
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.